109 related articles for article (PubMed ID: 7633307)
21. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
22. Implications of detection of minimal residual disease.
Wörmann B
Curr Opin Oncol; 1993 Jan; 5(1):3-12. PubMed ID: 8427891
[TBL] [Abstract][Full Text] [Related]
23. [How can chronic myeloid leukemia be cured with bone marrow transplantation?].
Saglio G
Med Clin (Barc); 1995 Mar; 104(11):415-7. PubMed ID: 7715260
[No Abstract] [Full Text] [Related]
24. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
25. [Residual disease: the hematologist's point of view].
Quesnel B; Preudhomme C
Bull Cancer; 2001 Jun; 88(6):571-5. PubMed ID: 11459703
[TBL] [Abstract][Full Text] [Related]
26. Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
Chen ZX; Kaeda J; Saunders S; Goldman JM
Chin Med J (Engl); 2004 Jul; 117(7):968-71. PubMed ID: 15265366
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease in chronic myeloid leukaemia patients.
Hochhaus A
Best Pract Res Clin Haematol; 2002 Mar; 15(1):159-78. PubMed ID: 11987922
[TBL] [Abstract][Full Text] [Related]
28. Lineage switch from acute myeloid leukemia to biphenotypic acute leukemia with acquisition of Philadelphia chromosome.
Lee HR; Kang SH; Kang HJ; Shin HY; Ahn HS; Kim HK; Park MH; Cho HI; Lee DS
Cancer Genet Cytogenet; 2008 Jul; 184(2):124-6. PubMed ID: 18617064
[No Abstract] [Full Text] [Related]
29. MicroRNAs: the primary cause or a determinant of progression in leukemia?
Bousquet M; Lodish HF
Expert Rev Hematol; 2011 Apr; 4(2):121-3. PubMed ID: 21495919
[No Abstract] [Full Text] [Related]
30. Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation.
Tamaki H; Ogawa H
Bone Marrow Transplant; 2004 Oct; 34(7):653-4. PubMed ID: 15258561
[No Abstract] [Full Text] [Related]
31. Autoimmunity and second malignancy in large granular lymphocytic leukaemia.
Bassan R; Rambaldi A; Barbui T
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():149-50. PubMed ID: 2785424
[No Abstract] [Full Text] [Related]
32. Survival from adult leukaemia in England and Wales up to 2001.
Milligan DW
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S119-20. PubMed ID: 18813244
[No Abstract] [Full Text] [Related]
33. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
[TBL] [Abstract][Full Text] [Related]
34. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal translocations in leukaemia.
Gauwerky CE; Croce CM
Semin Cancer Biol; 1993 Dec; 4(6):333-40. PubMed ID: 8142618
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia.
Calabrese G; Fantasia D; Di Gianfilippo R; Stuppia L; Di Lorenzo R; Palka G
Haematologica; 2006 Jul; 91(7):994-5. PubMed ID: 16818290
[TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
38. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
[TBL] [Abstract][Full Text] [Related]
39. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
Hur M; Park JY; Cho HC; Lee KM; Shin HY; Cho HI
Clin Lab Haematol; 2006 Jun; 28(3):154-9. PubMed ID: 16706930
[TBL] [Abstract][Full Text] [Related]
40. [Minimal residual disease in chronic myeloid leukemia in patients with long survival after allogeneic bone marrow transplantation].
García A; Román J; Brunet S; Andrés P; Baiget M; Torres A
Med Clin (Barc); 1995 Mar; 104(11):401-6. PubMed ID: 7715257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
